Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 190

1.

Clinical Utility of Random Anti-Tumor Necrosis Factor Drug-Level Testing and Measurement of Antidrug Antibodies on the Long-Term Treatment Response in Rheumatoid Arthritis.

Jani M, Chinoy H, Warren RB, Griffiths CE, Plant D, Fu B, Morgan AW, Wilson AG, Isaacs JD, Hyrich K, Barton A; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Collaborators.

Arthritis Rheumatol. 2015 May;67(8):2011-9. doi: 10.1002/art.39169.

PMID:
26109489
2.

Perceptions and experiences of using automated bolus advisors amongst people with type 1 diabetes: a longitudinal qualitative investigation.

Lawton J, Kirkham J, Rankin D, Barnard K, Cooper CL, Taylor C, Heller S, Elliott J; REPOSE Group.

Diabetes Res Clin Pract. 2014 Dec;106(3):443-50. doi: 10.1016/j.diabres.2014.09.011. Epub 2014 Oct 2.

3.

What should adult rheumatology know about paediatric rheumatology?

Tattersall R.

Rheumatology (Oxford). 2015 Jan;54(1):7-8. doi: 10.1093/rheumatology/ket495. Epub 2014 Mar 3. No abstract available.

PMID:
24591699
4.

Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritis.

Cordingley L, Prajapati R, Plant D, Maskell D, Morgan C, Ali FR, Morgan AW, Wilson AG, Isaacs JD; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS), Barton A.

Arthritis Care Res (Hoboken). 2014 Jun;66(6):861-8. doi: 10.1002/acr.22249.

5.

Testing the role of vitamin D in response to antitumour necrosis factor α therapy in a UK cohort: a Mendelian randomisation approach.

Yarwood A, Viatte S, Plant D, Morgan AW, Isaacs J, Wilson AG, Hyrich K, Eyre S, Barton A; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS).

Ann Rheum Dis. 2014 May;73(5):938-40. doi: 10.1136/annrheumdis-2013-204443. Epub 2013 Dec 9. No abstract available.

PMID:
24323394
6.
7.

Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment.

Mathews RJ, Robinson JI, Battellino M, Wong C, Taylor JC; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS), Eyre S, Churchman SM, Wilson AG, Isaacs JD, Hyrich K, Barton A, Plant D, Savic S, Cook GP, Sarzi-Puttini P, Emery P, Barrett JH, Morgan AW, McDermott MF.

Ann Rheum Dis. 2014 Jun;73(6):1202-10. doi: 10.1136/annrheumdis-2013-203276. Epub 2013 May 17.

PMID:
23687262
8.

High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.

Eyre S, Bowes J, Diogo D, Lee A, Barton A, Martin P, Zhernakova A, Stahl E, Viatte S, McAllister K, Amos CI, Padyukov L, Toes RE, Huizinga TW, Wijmenga C, Trynka G, Franke L, Westra HJ, Alfredsson L, Hu X, Sandor C, de Bakker PI, Davila S, Khor CC, Heng KK, Andrews R, Edkins S, Hunt SE, Langford C, Symmons D; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate; Wellcome Trust Case Control Consortium, Concannon P, Onengut-Gumuscu S, Rich SS, Deloukas P, Gonzalez-Gay MA, Rodriguez-Rodriguez L, Ärlsetig L, Martin J, Rantapää-Dahlqvist S, Plenge RM, Raychaudhuri S, Klareskog L, Gregersen PK, Worthington J.

Nat Genet. 2012 Dec;44(12):1336-40. doi: 10.1038/ng.2462. Epub 2012 Nov 11.

9.

The MAGICC and practical approach to rheumatology transition.

Tattersall RS.

Br J Hosp Med (Lond). 2012 Oct;73(10):552-7. No abstract available.

PMID:
23124284
10.
11.

Insulin manufacture: Marketing insulins.

Tattersall R.

BMJ. 2011 Jan 25;342:d471. doi: 10.1136/bmj.d471. No abstract available.

PMID:
21266433
12.

Transition: a rheumatology perspective.

Tattersall R, McDonagh JE.

Br J Hosp Med (Lond). 2010 Jun;71(6):315-9. Review.

PMID:
20551869
13.

Ex vivo magnetic resonance imaging of crystalline lens dimensions in chicken.

Tattersall RJ, Prashar A, Singh KD, Tokarczuk PF, Erichsen JT, Hocking PM, Guggenheim JA.

Mol Vis. 2010 Feb 2;16:144-53.

14.

Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis.

Hassan B, Maxwell JR, Hyrich KL; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate, Barton A, Worthington J, Isaacs JD, Morgan AW, Wilson AG.

Rheumatology (Oxford). 2010 Jan;49(1):43-7. doi: 10.1093/rheumatology/kep372. Epub 2009 Nov 19.

15.

Stiff and partly blind--after a first dose of steroid.

Tattersall RS, Boulton JG, Amos RS.

Lancet. 2008 Mar 22;371(9617):1044. doi: 10.1016/S0140-6736(08)60458-4. No abstract available.

PMID:
18358931
16.

Posture and cystic fibrosis.

Tattersall R, Walshaw MJ.

J R Soc Med. 2003;96 Suppl 43:18-22. Review. No abstract available.

17.

Systemic vasculitis following an unreported rat bite.

Tattersall RS, Bourne JT.

Ann Rheum Dis. 2003 Jul;62(7):605-6. No abstract available.

18.
19.

Pott's puffy tumour.

Tattersall R, Tattersall R.

Lancet. 2002 Mar 23;359(9311):1060-3. No abstract available.

PMID:
11937203
20.

Diseases the doctor (or autoanalyser) says you have got.

Tattersall R.

Clin Med. 2001 May-Jun;1(3):230-3. Review.

PMID:
11446622
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk